Sonoma Pharmaceuticals, Inc. Intellectual Property Contracts & Agreements
9 Contracts & Agreements
- License Agreements (9 contracts)
- License and Distribution Agreement, dated January 5, 2024, by and between Sonoma Pharmaceuticals, Inc. and NovaBay Pharmaceuticals, Inc (Filed With SEC on January 9, 2024)
- Exclusive License and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Anlicare International dated January 18, 2022 (Filed With SEC on January 20, 2022)
- Exclusive License and Distribution Agreement between the Company and Dyamed Biotech Pte, Ltd., dated November 4, 2021 (Filed With SEC on November 9, 2021)
- License, Distribution and Supply Agreement by and between Sonoma Pharmaceuticals, Inc. and Brill International, S.L. dated May 19, 2020 (Filed With SEC on May 26, 2020)
- Exclusive License and Distribution Agreement entered into by and between Sonoma Pharmaceuticals, Inc. and EMS S.A. dated June 4, 2018 (Filed With SEC on June 5, 2018)
- AMENDMENT NO. 3 TO LICENSE AND SUPPLYAGREEMENT (Filed With SEC on February 6, 2014)
- AMENDMENT NO. 2 TO LICENSE AND SUPPLYAGREEMENT (Filed With SEC on November 19, 2013)
- AMENDMENT NO. 1 TO LICENSE AND SUPPLY AGREEMENT (Filed With SEC on November 19, 2013)
- PUBLIC HEALTH SERVICE PATENT LICENSE AGREEMENT EXCLUSIVE COVER PAGE (Filed With SEC on November 3, 2011)
